Ledger.Open graph →
SEC Form D · Amendment · filed August 15, 2014

Navitor Pharmaceuticals, Inc

Offering
$23.5M
Sold
$13.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

George Vlasuk · Cambridge, MAExec · DirectorMarian Nakada · Cambridge, MADirectorJean-Francois Formela · Cambridge, MADirectorBrian Gallagher · Cambridge, MADirectorAlan Crane · Cambridge, MADirectorRick Lundberg · Cambridge, MAExecMark P. Hagen · Sioux Falls, SDDirectorAugustin Huret · Annandale, VADirectorGregory Jennings · Annandale, VADirectorJoseph Weber · El Segundo, CADirectorGarett Ochs · SEATTLE, WAExec · DirectorColton Anderson · SEATTLE, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗